Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

It's little secret that America has a weight problem. For decades, Americans have embraced and abandoned countless ...

Eli Lilly on Thursday reported promising results for a daily pill that could serve as an alternative to injectable ...

Eli Lilly GLP-1 pill orforglipron could revolutionize the weight loss world by the end of 2025 after promising Phase 3 trial ...

Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...

Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

The positive data gives Eli Lilly the green light to file the drug with the FDA by the end of the year for a weight loss indication.

Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at certain dosages.

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

The new, limited-edition whisky is a delightful sipper. Here's everything you need to know, including tasting notes, price, and how it's made ...